These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 35919062)
1. Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach. Karabacak M; Ozkara BB; Mordag S; Bisdas S Quant Imaging Med Surg; 2022 Aug; 12(8):4033-4046. PubMed ID: 35919062 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis. Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643 [TBL] [Abstract][Full Text] [Related]
3. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance. Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis. Chen X; Lei J; Wang S; Zhang J; Gou L Front Oncol; 2024; 14():1409760. PubMed ID: 39139289 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive Determination of Bhandari AP; Liong R; Koppen J; Murthy SV; Lasocki A AJNR Am J Neuroradiol; 2021 Jan; 42(1):94-101. PubMed ID: 33243896 [TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI Sequences to Predict Kasap DNG; Mora NGN; Blömer DA; Akkurt BH; Heindel WL; Mannil M; Musigmann M Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672080 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of Radiomics in Predicting Di Salle G; Tumminello L; Laino ME; Shalaby S; Aghakhanyan G; Fanni SC; Febi M; Shortrede JE; Miccoli M; Faggioni L; Cosottini M; Neri E Radiol Artif Intell; 2024 Jan; 6(1):e220257. PubMed ID: 38231039 [TBL] [Abstract][Full Text] [Related]
8. Deep-learning and conventional radiomics to predict Zhang H; Fan X; Zhang J; Wei Z; Feng W; Hu Y; Ni J; Yao F; Zhou G; Wan C; Zhang X; Wang J; Liu Y; You Y; Yu Y Front Oncol; 2023; 13():1143688. PubMed ID: 37711207 [TBL] [Abstract][Full Text] [Related]
9. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas. Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485 [TBL] [Abstract][Full Text] [Related]
10. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion. Chen SC; Lo CM; Wang SH; Su EC BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275 [TBL] [Abstract][Full Text] [Related]
11. Using radiomics based on multicenter magnetic resonance images to predict isocitrate dehydrogenase mutation status of gliomas. Liu Y; Zheng Z; Wang Z; Qian X; Yao Z; Cheng C; Zhou Z; Gao F; Dai Y Quant Imaging Med Surg; 2023 Apr; 13(4):2143-2155. PubMed ID: 37064376 [TBL] [Abstract][Full Text] [Related]
12. Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas. Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070 [TBL] [Abstract][Full Text] [Related]
13. A fusion model integrating magnetic resonance imaging radiomics and deep learning features for predicting alpha-thalassemia X-linked intellectual disability mutation status in isocitrate dehydrogenase-mutant high-grade astrocytoma: a multicenter study. Liu Z; Xu X; Zhang W; Zhang L; Wen M; Gao J; Yang J; Kan Y; Yang X; Wen Z; Chen S; Cao X Quant Imaging Med Surg; 2024 Jan; 14(1):251-263. PubMed ID: 38223098 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma. Çelik S; Öven BB; Demir MK; Yılmaz EÇ; Kanan D; Özdamarlar U; Emirzeoglu L; Yapıcıer Ö; Kılıç T Clin Neurol Neurosurg; 2021 Aug; 207():106745. PubMed ID: 34146841 [TBL] [Abstract][Full Text] [Related]
15. Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis. Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ Eur Radiol; 2019 Feb; 29(2):745-758. PubMed ID: 30003316 [TBL] [Abstract][Full Text] [Related]
16. The role of APT imaging in gliomas grading: A systematic review and meta-analysis. Sotirios B; Demetriou E; Topriceanu CC; Zakrzewska Z Eur J Radiol; 2020 Dec; 133():109353. PubMed ID: 33120241 [TBL] [Abstract][Full Text] [Related]
17. Multivariable non-invasive association of isocitrate dehydrogenase mutational status in World Health Organization grade II and III gliomas with advanced magnetic resonance imaging T2 mapping techniques. Kern M; Auer TA; Fehrenbach U; Tanyildizi Y; Picht T; Misch M; Wiener E Neuroradiol J; 2020 Apr; 33(2):160-168. PubMed ID: 31957551 [TBL] [Abstract][Full Text] [Related]
18. Preoperative Determination of Isocitrate Dehydrogenase Mutation in Gliomas Using Spectral Editing MRS: A Prospective Study. Nguyen TB; Melkus G; Taccone M; Moldovan ID; Ghinda D; Gotfrit R; Torres CH; Zakhari N; Chakraborty S; Woulfe J; Jansen G; McInnes MD; Thornhill RE; Cameron I; AlKherayf F J Magn Reson Imaging; 2021 Feb; 53(2):416-426. PubMed ID: 32940938 [TBL] [Abstract][Full Text] [Related]
19. Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas. Suh CH; Kim HS; Park JE; Jung SC; Choi CG; Woo DC; Lee HB; Kim SJ Radiol Imaging Cancer; 2020 Jul; 2(4):e190083. PubMed ID: 33778723 [TBL] [Abstract][Full Text] [Related]
20. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics. Choi YS; Bae S; Chang JH; Kang SG; Kim SH; Kim J; Rim TH; Choi SH; Jain R; Lee SK Neuro Oncol; 2021 Feb; 23(2):304-313. PubMed ID: 32706862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]